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Abstract
The gene encoding the VP8* trypsin-cleavage product of the VP4 protein of porcine rotavirus strain A34 was sequenced, and the
predicted amino acid (aa) sequence was compared to the homologous region of all known P genotypes. The aa sequence of the VP8* of
strain A34 shared low identity, ranging from 39% (bovine strain B223, P8[11]) to 76% (human strain 69M, P4[10]), with the homologous
sequences of representative strains of the remaining 21 P genotypes. Phylogenetic relationships showed that the VP8* of strain A34 shares
a common evolutionary lineage with those of human 69M (P4[10]) and equine H-2 (P4[12]) strains. Hyperimmune sera raised to strain A34
and to a genetic reassortant strain containing the VP4 gene from strain A34, both with high homologous neutralization titer via VP4, failed
to neutralize strains representative of 15 different P genotypes. These results indicate that strain A34 should be considered as prototype of
a new P genotype and serotype (P14[23]) and provide further evidence for the vast genetic and antigenic diversity of group A rotaviruses.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Group A rotaviruses are a major cause of acute gastroen-
teritis in young children and in a wide variety of domestic
animals, including pigs. Rotaviruses are characterized by a
genome consisting of 11 segments of double-stranded RNA
enclosed in a triple-layered protein capsid (Estes, 2001). The
two outer capsid proteins of group A rotaviruses, VP4 and
VP7, independently elicit neutralizing antibodies, induce pro-
tective immunity, and are used to classify rotavirus strains into
P (for protease-sensitive) and G (for glycoprotein) serotypes,
respectively, based on neutralization determinants located on
the surface of VP4 and VP7 (Estes, 2001).
Serotype specificity determined by cross-neutralization
assays using hyperimmune sera against the whole virus is
mainly defined by VP7, and so far 15 G serotypes have been
identified (Hoshino et al., 2002). To determine the VP4
types, P genotyping (defined by sequence analysis and/or
nucleic acid hybridization data) is used more frequently
because of the speed sequencing and the difficulties in
producing antibodies suitable to distinguish among P sero-
types. Of 22 different P genotypes (designated in brackets),
only 13 P serotypes have been identified with available
antisera or anti-VP4 monoclonal antibodies (MAbs) that
recognize specific VP4 neutralization specificities (Okada et
al., 2000; Hoshino et al., 2002; Martella et al., submitted for
publication). Rotavirus strains sharing 89% VP4 amino
acid (aa) sequence identities are considered to belong to the
same P genotype, while those sharing VP4 aa sequence
identities of89% belong to different genotypes (Gorziglia
et al., 1990; Estes, 2001). Moreover, the greatest aa diver-
gence in VP4 is seen between aa 71 and 204 of the VP4
trypsin-cleavage product VP8*, which correlates with VP4
genotype specificity (Larralde et al., 1991; Larralde and
Gorziglia, 1992). Therefore, sequencing of this prominent
region of divergence in VP8* can be used to predict the VP4
genotype of a particular rotavirus strain.
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Among porcine rotaviruses, seven G serotypes (G1,
G3–5, and G9–11) have been described (Saif et al., 1994;
Ciarlet and Liprandi, 1994; Ciarlet et al., 1994a, 1995,
1997). The most widespread porcine rotavirus G serotypes
are G3, G4, and G5, which are usually associated with
serotypes P9[7] or P2B[6], corresponding to the prototype
OSU (G5) or Gottfried (G4) strains, respectively (Liprandi
et al., 1991; Saif et al., 1994). Rotavirus strains isolated
from or detected in porcine stool samples of additional P
types (P7[5], P1A[8], P13[13], and P[19]) associated with
G3, G5, or G9 porcine strains have also been described
(Santos et al., 1999; Burke et al., 1994; Huang et al., 1993).
In this article, we describe a novel genotype and serotype of
VP4 carried by a serotype G5 porcine rotavirus strain iso-
lated in Venezuela.
Results and discussion
Porcine rotavirus strain A34 was isolated from a diarrheic
piglet of farm LE during a large epidemiological study on the
incidence of rotavirus infections in several pig farms in north-
central Venezuela (Ciarlet et al., 1995). The majority of the
rotavirus-positive samples from the LE farm, obtained in 1985,
exhibited identical RNA profiles (data not shown). One sam-
ple, A34, was adapted to growth in MA104 cells (Ciarlet et al.,
1995). The electropherotype of the cell-adapted strain was
identical to that of the original fecal sample (data not shown).
Rotavirus strain A34 exhibited a “long” RNA electropherotype
typical of many porcine strains, possessed SGI specificity and
a Wa-like NSP4 genogroup, and belonged to serotype G5
(Ciarlet et al., 1995, 2000). Early attempts to determine the P
serotype specificity were unsuccessful, but cross-neutralization
data indicated that the P serotype of strain A34 was different
from that of OSU (P9[7]) and Gottfried (P2B[6]) (Liprandi et
al., 1991; Ciarlet et al., 1995).
To determine the P genotype of strain A34, we se-
quenced a large portion (nt 46 to 760) of the VP8* trypsin-
cleavage product of VP4 coding for aa 13 to 250, which
includes the region spanning aa 71 and 204 that correlates
with VP4 genotype specificity (Larralde et al., 1991; Lar-
ralde and Gorziglia, 1992). The deduced aa sequence for the
gene encoding aa 13 to 250 of the VP8* of the porcine strain
A34 was compared with those of rotavirus strains represen-
tative of all 22 P genotypes (Fig. 1 and Table 1 ). As with
most rotavirus strains, the potential trypsin-cleavage sites at
residues 231, 241, and 247, and the prolines at residues 68,
71, 225, and 226 were conserved in the VP8* of strain A34.
In addition, the cysteine at position 216 in VP8*, which is
conserved among other P genotypes, except in the P4[10]
human rotavirus strain 69M and all P8[11] bovine or human
rotavirus strains, was conserved in the VP8* of strain A34.
The highest degree of aa identity (76%) was found with the
P4[10] human rotavirus strain 69M isolated in Indonesia.
With the remaining 21 P genotypes, the aa identity of the
VP8* of the strain A34 ranged from 75% (Si/RRV, P5B[3])
to 37% (Bo/B223, P8[11]). Since it has been established
that rotavirus strains that exhibit a VP8* aa identity of
approximately 89% belong to the same P genotype (Gor-
ziglia et al., 1990), our results indicate that the Venezuelan
porcine rotavirus strain A34 represents a novel P genotype.
Maximum likelihood phylogenetic analysis of the de-
duced aa sequences of the VP8* of strain A34 provided a
molecular basis for its relatedness to previously established
rotavirus P genotypes (Fig. 2). In the phylogenetic tree, the
VP8* of the strain A34 clustered on a clearly distinct
branch, close to those of the P4[10] human rotavirus strain
69M and P4[12] equine rotavirus strains as expected. A
similar topology was obtained using either distance (neigh-
bor- joining) or parsimony methods (data not shown).
Therefore, the Venezuelan porcine rotavirus strain A34
qualifies as a new P genotype, tentatively called P[23].
Although initial work with some human rotavirus strains
revealed that distinct P serotypes matched distinct P geno-
types (Gorziglia et al., 1990), recent work has revealed that
there is not a complete correlation between P serotype and
P genotype (Li et al., 1996; Hoshino et al., 1998, 2002; Isˇa
and Snodgrass, 1994). A P genotype, which is determined
by sequencing and/or hybridization methods, is not always
identical to a P serotype, which is determined by serological
methods. For example, the VP4s of the human rotavirus
69M (P[10]) and the equine rotavirus H-2 (P[12]) share
85% aa identity, but belong to the same P serotype (P4)
based on reciprocal neutralization titers (Li et al., 1996; Isˇa
and Snodgrass, 1994). Therefore, since the establishment of
a new P genotype does not always guarantee a new P
serotype, the P serotype specificity of the rotavirus strain
A34 was analyzed in one-way cross-neutralization tests
using representative rotavirus strains of different P serotype
specificities, the homologous antiserum, and an antiserum
against an A34  RF reassortant, R4-12 (P[?],G6), thereof
prepared for this study, containing 10 genes from porcine
rotavirus strain A34 and only the VP7 cognate gene from
bovine rotavirus strain RF (Fig. 3). Since the VP4 and VP7
interactions affect the expression of phenotypes of one or
both capsid proteins (Chen et al., 1992), we included strains
of the same P type with different G serotypes as controls in
cross-neutralization assays.
Both hyperimmune rabbit antisera had high neutraliza-
tion titers via VP4 (1:25,600) as indicated by the reactivity
of the anti-A34 serum with the reassortant strain R4-12 and
of the anti-R4-12 serum to the A34 strain (Table 2). Both
sera failed to neutralize (neutralization titers  1:800; i.e.,
32-fold less that the titer supposedly to VP4) rotavirus
strains representative of serotypes 1A, 1B, 2A, 2B, 3, 4, 8,
9, 10, 11 as well as those of unknown P serotype of turkey
(Ty-1, P[17]), chicken (Ch-2, P[17]), and equine (L338,
P[18]) rotavirus strains. A number of weak neutralization
reactions (1:1600 or 1:3200) were observed with each se-
rum but against different rotavirus strains. The anti-A34
serum neutralized both RF and UK strains, which share the
same VP7 type (G6), but not P types (P1[6] and P7[5],
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respectively) at titers of 1:1600 (Table 2). The anti-R4-12
serum neutralized simian RRV (P5B[3],G3) to a titer of
1:3200, while rotavirus strains belonging to serotype P4[12]
(H-2) and genotype P[13] (A46, Clone 8) were neutralized
at titers of 1:1600, which is equivalent to 8- and 16-fold
less, respectively, than that to the A34 strain. With the
exception of strain A46, which shares the same G serotype
that strain A34, strains RRV, H-2, and Clone 8 showed
much lower reactivity with the anti-A34 serum, suggesting
that the cross-neutralization observed with the anti-R4-12
serum was not due to VP4. These data strongly suggest that
A34 represents a new P serotype, tentatively called P14,
completing the nomenclature of the porcine rotavirus A34
strain to P14[23].
Rotavirus infectivity is enhanced by proteolytic cleavage
of VP4 into VP8* and VP5* and VP4 has been associated
with hemagglutination, restriction of growth in cell culture,
virulence, initial virus attachment to cells, protease sensi-
tivity associated to plaque formation, and host range restric-
tion (Arias et al., 1996; Bridger et al., 1992; Espejo et al.,
1981; Greenberg et al., 1983; Kalica et al., 1983; Offit et al.,
1986; Ciarlet et al., 1998, 2002). Recent studies showed that
the initial interaction of rotavirus with SA residues on the
cell surface correlates with the VP4 genotype (Ciarlet et al.,
2002). Sequence analysis of the VP8* region of VP4,
known to interact with SA residues, of the porcine rotavirus
A34 strain predicts that the A34 strain does not require SA
residues on the cell surface for efficient infectivity. In fact,
when the SA-dependency of the porcine rotavirus strain
A34 was tested, the infectivity of strain A34 was unaffected
by neuraminidase treatment of MA104 cells (Fig. 4).
In recent years, epidemiological surveillance to monitor
the appearance of novel rotavirus antigenic types has inten-
sified throughout the world, yielding evidence for the in-
creasing antigenic diversity of group A rotaviruses (Rao et
al., 2000; Okada and Matzumoto, 2002; Martella et al.,
submitted for publication) and revealed that the immuno-
logical relationships among different rotavirus strains are
complex. Rotavirus A34-like strains, identified as such by
identity of electropherotype profiles, circulated in the LE
pig farm for over 1 year. Thus, the determination of the
relative prevalence of the novel P14[23] type among por-
Fig. 1. Comparison of the deduced amino acid sequence of the VP8* trypsin cleavage product of the VP4 spike protein of the Venezuelan porcine rotavirus
strain A34 with a selection of rotavirus strains representative of genotypes P[1] through P[22]. The highly conserved cysteine ( ), prolines (E), and arginines
() are indicated. The number of amino acids is based on porcine rotavirus A34, and for optimal alignment, gaps (---) were introduced in the sequences. The
first 12 highly conserved amino acids (*) in the sequence of the porcine rotavirus strain A34 were not determined. The GenBank Accession No. of the VP4
sequences are listed in Table 1. Si, simian; Eq, equine; Po, porcine; Ca, canine; Bo, bovine; Mu, murine; Hu, human; Pi, pigeon; Ov, ovine; La, lapine.
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cine strains is needed, but in the future, P-serotype-specific
MAbs to A34 may facilitate its detection in field samples.
The P type most commonly found circulating in pigs is
P9[7] (Saif et al., 1994; Santos et al., 1999; Huang et al.,
1993; Ciarlet et al., 2002; Winiarczyk et al., 2002). It is not
known whether the prevalence of the P9[7] type among pig
populations throughout the world relates to the fact that
P9[7] strains are more commonly associated with disease or
that they spread more rapidly, thereby facilitating their
identification at any given time. A better understanding of
the rotavirus epidemiology will contribute to the optimiza-
tion of current vaccines and prevention programs of rotavi-
rus diarrhea in humans and animals. Furthermore, precise
evaluation of antigenic or molecular diversity among do-
mestic animal herd populations is of critical importance for
the development of an effective vaccine because animal
rotaviruses might be involved in interspecies transmission
or reassortment in humans.
Materials and methods
Virus isolation
The porcine rotavirus strain A34 was isolated in 1985
from the feces of a 3-week-old diarrheic piglet from one
farm located in the central region of Venezuela (Liprandi et
al., 1991; Ciarlet et al., 1995). The virus was first adapted to
grow in African green monkey kidney (MA104) cell mono-
layers in roller tubes in the presence of 1 g/ml porcine
trypsin (type IX; Sigma Chemical Co., St. Louis, MO) and
was then plaque-purified three times before characteriza-
tion. The A34 isolate has been shown to possess serotype
G5, subgroup (SG) I, and NSP4 genotype B (Wa-like)
specificities (Ciarlet et al., 1995, 1996, 2000).
Rotavirus strains and antibodies
Bovine rotavirus strain RF (P6[1],G6) was provided by J.
Cohen (Institut National de la Recherche´é Agronomique,
Jouy-en-Josas, France). Porcine rotavirus strain OSU
(P9[7],G5) was obtained from E. Bohl (Ohio Agricultural
Research and Development Center, Wooster, OH, USA).
Bovine rotavirus strains UK (P7[5],G6) and B223
(P8[11],G10), and equine rotavirus strain L338
(P[18],G13), were provided by D. Snodgrass and P. Isˇa
(Moredun Research Institute, Edinburgh, Scotland, UK).
Human rotavirus strain M37 (P2A[6],G1) was supplied by I.
Pe´rez-Schael (Instituto de Biomedicina, Caracas, Venezue-
la). Additional reference Gottfried (P2B[6],G4); simian
SA11 (P5B[2],G3), RRV (P5B[3],G3); lapine C-11
(P11[14],G3); murine EW (P10[16],G3); equine H-2
(P4[12],G3); turkey Ty-1 (P[17],G7); chicken Ch-2
(P[17],G7); and human Wa (P1A[8],G1), DS-1
(P1B[4],G2), ST3 (P2A[6],G4), K8 (P3[9],G1), and 69M
(P4[10],G8) rotavirus strains were kindly provided by M.
Gorziglia and Y. Hoshino (National Institute of Allergy and
Infectious Diseases, Bethesda, MD). The origins of porcine
LCA843 (P9[7],G3) and equine FR5 (P[12],G14) rotavirus
strains were described previously (Ciarlet et al., 1994b,
1995), and those of the porcine strains A46 (P[13],G5) and
Clone 8 (P[13],G3) are part of an unpublished study (F.
Liprandi, Z. Bastidas, J. E. Ludert, F. H. Pujol, M. Ciarlet,
and M. Gorziglia).
Table 1
Percentage (%) nucleotide (nt) and amino acid (aa) sequence identity of
the VP8* trypsin-cleavage product of the VP4 of the Venezuelan












Bo/RF P6[1] G6 73.4 74.5
Si/SA11 P5B[2] G3 71.8 73.4
Ca/CU-1 P5A[3] G3 73.2 73.9
Si/RRV P5B[3] G3 73.1 74.7
Hu/RV-5 P1B[4] G2 65.0 58.1
Bo/UK P7[5] G6 64.1 63.5
Hu/St. Thomas 3 P2A[6] G4 64.4 58.9
Po/Gottfried P2B[6] G4 65.4 63.9
Po/OSU P9[7] G5 70.9 73.0
Hu/Wa P1A[8] G1 64.6 58.1
Hu/K8 P3[9] G1 61.1 55.6
Hu/69M P4[10] G8 71.8 76.3
Bo/B223 P8[11] G10 52.0 36.9
Eq/H-2 P4[12] G3 69.9 72.6
Eq/FI-14 P4[12] G3 71.8 72.2
Eq/FI-23 P4[12] G14 72.4 73.9
Po/MRD-13 P[13] G3/G5 67.7 61.7
Hu/PA169 P11[14] G6 60.1 57.3
Ov/Lp14 P[15] G10 70.0 73.0
Mu/EB P10[16] G3 65.1 63.5
Pi/PO-13 P[17] G7 54.6 37.7
Eq/L338 P[18] G13 72.2 70.1
Po/4F P12[19] G3 67.2 61.8
Mu/EHP P13[20] G3 68.0 73.0
Bo/Hg18 P[21] G15 66.5 66.4
La/160/01 P[22] G3 66.8 61.4
a Rotavirus strain followed by species of origin. Abbreviations: Hu,
human; Bo, bovine; Po, porcine; Eq, equine; Mu, murine; Ov, ovine; Ca,
canine; Si, simian; Ov, ovine; Pi, pigeon; La, lapine.
b The following VP8* sequences were obtained from GenBank database
(Accession No.): bovine UK bovine RF (U65924), UK (M22306), B223
(D13394), Hg18 (AF237665); porcine Gottfried (M33516), OSU
(X13190), MDR-13 (L07886), 4F (L10359); equine H-2 (L04638), FI-14
(D13398), FI-23 (D16342), L338 (L26888); ovine Lp-14 (L11599); lapine
160/01 (AF526374); murine EB (U08419), EHP (U08424); human Wa
(M96825), K8 (M28349), 69M (M60600), PA169 (D14724), RV-5
(M32559), ST3 (L33895); and simian SA11 (M23188), RRV (M18736);
canine CU-1 (D13401); and pigeon PO-13 (L41492) rotavirus strains.
c P genotype is designated in brackets while serotype (when known)
precedes P genotype (Estes, 2001).
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Hyperimmune sera to porcine rotavirus strain A34 and
the reassortant rotavirus R4-12 (see below) were raised in
New Zealand White rabbits from rotavirus-free colonies as
reported previously (Ciarlet et al., 1994a). Serotype G5-
specific neutralizing MAbs (N-MAbs) IC3 and IC10, di-
rected against the VP7 of porcine strains A34 and A46,
respectively, were described elsewhere (Ciarlet et al., 1996).
Cross-reactive N-MAb 57/8 (neutralizes rotavirus strains of
serotypes G3, G4, G6, G9, G10, and G14) was obtained
from by D. Benfield (South Dakota State University, Brook-
ings, SD). Serotype P1-specific N-MAbs 103, 152 and 113
directed against the VP8* of bovine strain RF (F. Liprandi
and M. Gerder, unpublished data) were also used.
Production of the reassortant rotavirus strain R4-12
(A34  RF)
To obtain immunological reagents specific to the VP4 type
of the porcine rotavirus A34 (P[?],G5), a reassortant carrying
the VP7 of the bovine rotavirus strain RF (P6[1],G6) on the
background of porcine strain A34 was produced. The reassor-
tant strain R4-12 (A34  RF) was generated using selection
with N-MAbs as described (Ciarlet et al., 1996), with modifi-
cations. Briefly, trypsin-treated (10 g/ml for 30 min at 37°C)
parental viruses (A34 and RF, each plaque purified three times)
were cocultivated in MA104 cells grown to confluency in 96
microtiter plates. First, the cells were inoculated with 50 l of
A34 at a multiplicity of infection (m.o.i.) of 5. After 45 min at
37°C, 50 l of RF (m.o.i. 5) was added to the cells, and the
cells were incubated for an additional hour. Then, the cells
were washed with Eagle’s minimal essential medium (Sigma),
and the infection was allowed to proceed for 48 h at 37°C.
After two cycles of freezing and thawing, 100 l of trypsin-
treated progeny virus was incubated with 1 l each of ascitic
fluid of N-MAbs 1C3, 1C10, 103, 152, and 113 for 2 h at 37°C.
The virus–N-MAb mixture was inoculated onto MA104 cell
monolayers in roller tubes in the presence of 1 g/ml porcine
trypsin and incubated at 37°C until cytopathic effect appeared.
Progeny virus was plated after the same antibody mixture
treatment, and individual plaques were picked and amplified in
tubes. The electropherotype of the amplified plaques was
tested by PAGE and silver staining. Furthermore, the desired
serotype specificity (P[?],G6) was confirmed by lack of reac-
tivity of the amplified plaques with the N-MAbs against the
VP8* of RF and the VP7 of A34, and a positive neutralization
reaction of the virus with N-MAb 57/8, which neutralizes RF
via VP7. One clone (R4-12) was selected and plaque-purified
three times before confirming its serotype specificity again.
Fluorescent focus neutralization assay (FFNA)
The serotype specificity was assigned by FFNA essen-
tially as described (Ciarlet et al., 1994a, 1994b, 1995, 1997),
with the endpoint determined as the serum dilution produc-
ing a 66% reduction in the number of fluorescent foci.
Different viral serotypes were defined when the ratio be-
Fig. 2. Maximum likelihood phylogenetic tree of the VP8* of group A rotavirus displaying the relationships between porcine strain A34 and strains
representative of the 21 genotypes recognized to date. The phylogenetic tree, based on residues 13 to 251 of the VP8* trypsin cleavage product of VP4, was
reconstructed using TREE-PUZZLE (Strimmer and von Haeseler, 1996). The tree is unrooted and drawn to scale, indicated in maximum likelihood distances
units. The percentage support values are indicated for each internal branch. The support value for the multifurcation is indicated by the arrow. The GenBank
Accession No. of the VP4 sequences are listed in Table 1. Si, simian; Eq, equine; Po, porcine; Ca, canine; Bo, bovine; Mu, murine; Hu, human; Pi, pigeon;
Ov, ovine; La, lapine.
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tween homologous and heterolgous titers of antisera was
16-fold, whereas if this ratio was 16-fold, the serotypes
of the viruses were considered the same.
Viral infectivity assay
The sialic acid (SA) dependence or independence of the
infectivity of the porcine A34 strain was tested on confluent
MA104 cells grown in 96-well plates treated for 1 h at 37°C
with 100 l of twofold dilutions of neuraminidase from
Vibrio cholera (Sigma Chemical Co), starting from 40 mU/
ml, or with 100 l of TNC buffer [10 mM Tris (pH 7.5), 140
mM NaCl, 10 mM CaCl2] as a control, as described else-
where (Ciarlet et al., 2002). Viral infectivity was expressed
as the percentage of fluorescence foci units (FFU) in neura-
minidase-treated cells with respect to those obtained in
control (TNC buffer-treated) cells. In all assays one sialic
acid dependent (RRV) and one independent strain (DS-1)
(Ciarlet et al. 2002) were tested in parallel.
Nucleotide sequence determination
The VP4 trypsin-cleavage product VP8* encoded by the
5 end of gene 4 of porcine strain A34 was amplified by
reverse transcription mediated polymerase chain reaction
(RT-PCR) from in vitro produced transcripts (Gorziglia et
al., 1986). Negative-sense oligonucleotide 794 (5 TAT
ATT GCA TTT CTT TCC 3, nucleotide positions 794 to
811 from porcine OSU strain) was used for the RT reaction.
Positive-sense oligonucleotide D10 (5 GGC TAT AAA
ATG GCT TCG C 3), complementary to the conserved first
20 nucleotides of gene 4, was included for the PCR reaction.
The 811 base pairs (bp) VP8* fragment was purified
through a spin cartridge containing silica-based membrane
(Concert Rapid PCR Purification System, GIBCO-BRL,
Grand Island, NY) or after extraction of the band from
low-melting agarose (Concert Matrix Gel Extraction Sys-
tem, GIBCO-BRL) according to the manufacturer’s proto-
cols. The sequence of the VP8* of the porcine rotavirus
strain A34 was obtained by direct sequencing of the PCR-
generated fragment by the fluorescent chain method (Big
Dye Terminator Cycle Sequencing Ready Reaction, Perkin–
Elmer Applied Biosystems, Foster City, CA) using an ABI-
377 automatic DNA sequencer (Perkin–Elmer Applied Bio-
systems). Additional internal oligonucleotides were chosen
on the basis of the sequences obtained when necessary to
complete the analysis. For sequencing, three distinct PCR
amplicons were analyzed. The VP8* gene sequence of por-
cine rotavirus strain A34 has been deposited in the GenBank
data library under the Accession No. AY174094.
Phylogenetic analysis
The VP8* sequence alignment was created using the
Clustal W algorithm with the BLOSUM series of weight ma-
trices (Thompson et al., 1994). Initial gap opening penalty and
Fig. 3. Electrophoresis migration patterns of genomic dsRNAs of porcine
rotavirus strain A34 (lane 1), reassortant rotavirus A34  RF (lane 2), and
bovine rotavirus strain RF (lane 3). Samples were subjected to electro-
phoresis at 10 mA for 16 h in a 7% polyacrylamide gel, and the resulting
migration patterns of the genome segments were visualized by staining the
gel with silver nitrate.
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gap extension penalties were set to 10 and 0.05, respectively.
The gap separation range was 8. A maximum likelihood tree of
the rotavirus VP8* was constructed using the TREE-PUZZLE
program (http://www.tree-puzzle.de/; Strimmer and von Hae-
seler, 1996), with the JTT model of amino acid substitution and
a mixed model of substitution rate heterogeneity (1 invariable
rate  8 gamma distributed rates). All parameters were esti-
mated from the data by the program. Philogenetic trees were
drawn using Tree View (Page, 1996).
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Table 2
Neutralizing activity of rabbit hyperimmune serum against VP4 of porcine rotavirus strain A34 (P[?], G5) with different rotavirus strains belonging to
established P serotypes
Rotavirus strain Species of origin Serotype Titera of antiserum to indicated rotavirus strains
P [genotype]b G A34 (P[?], G5) A34  RF (P[?], G6)
A34 Porcine [?] 5 204,800 25,600
A34  RF Reassortant [?] 6 25,600 102,400
RF Bovine 6[1] 6 1600 51,200
SA11 Simian 5B[2] 3 100 400
RRV Simian 5B[3] 3 200 3200
DS-1 Human 1B[4] 2 800 400
UK Bovine 7[5] 6 1600 51,200
M37 Human 2A[6] 1 200 200
St. Thomas 3 Human 2A[6] 4 200 200
Gottfried Porcine 2B[6] 4 100 100
OSU Porcine 9[7] 5 25,600 400
LCA843 Porcine 9[7] 3 100 400
Wa Human 1A[8] 1 100 200
K8 Human 3[9] 1 100 100
69M Human 4[10] 8 200 200
B223 Bovine 8[11] 10 400 100
H-2 Equine 4[12] 3 100 1,600
FR5 Equine 4[12] 14 100 100
A46 Porcine [13] 5 51,200 1600
Clone 8 Porcine [13] 3 400 1600
C-11 Lapine 11[14] 3 100 400
EW Murine 10[16] 3 100 400
Ty-1 Turkey [17] 7 400 400
Ch-2 Chicken [17] 7 100 400
L338 Equine [18] 13 100 100
a Numbers in the table represent the reciprocal values of neutralization titers of sera with indicated rotavirus strain. Neutralization titer is defined as the
highest serumdilution which inhibits 66% of infectious foci, measured by immunofluorescence. VP7 homologous titers are in boldface type. VP4
homologous titers are underlined. VP7 and VP4 homologous titers are in boldface type and underlined. NT, not tested.
b P genotype is designated in brackets while serotype (when known) precedes P genotype.
Fig. 4. Effect of treatment of MA104 cells with neuraminidase on the infec-
tivity of strain A34. Results with a sialic acid independent strain (DS-1) and a
sialic acid dependent strain (RRV), tested in the same experiment, are in-
cluded. Viral infectivity is expressed as the percentage of the number of FFU
in neuraminidase-treated cells relative to the number in the control cells.
Results from one experiment representative of a series of four.
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nal de Ciencia, Tecnologı´a e Innovacio´n (FONACIT;
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